Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Seropositivity and higher immunoglobulin g antibody levels against cytomegalovirus are associated with mortality in the population-based European prospective investigation of Cancer-Norfolk cohort.

Gkrania-Klotsas E, Langenberg C, Sharp SJ, Luben R, Khaw KT, Wareham NJ.

Clin Infect Dis. 2013 May;56(10):1421-7. doi: 10.1093/cid/cit083. Epub 2013 Feb 26.

2.

Higher immunoglobulin G antibody levels against cytomegalovirus are associated with incident ischemic heart disease in the population-based EPIC-Norfolk cohort.

Gkrania-Klotsas E, Langenberg C, Sharp SJ, Luben R, Khaw KT, Wareham NJ.

J Infect Dis. 2012 Dec 15;206(12):1897-903. doi: 10.1093/infdis/jis620. Epub 2012 Oct 8.

PMID:
23045624
3.

Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up.

Roberts ET, Haan MN, Dowd JB, Aiello AE.

Am J Epidemiol. 2010 Aug 15;172(4):363-71. doi: 10.1093/aje/kwq177. Epub 2010 Jul 21.

4.

Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States.

Simanek AM, Dowd JB, Pawelec G, Melzer D, Dutta A, Aiello AE.

PLoS One. 2011 Feb 17;6(2):e16103. doi: 10.1371/journal.pone.0016103.

5.
6.

Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study.

Wang GC, Kao WH, Murakami P, Xue QL, Chiou RB, Detrick B, McDyer JF, Semba RD, Casolaro V, Walston JD, Fried LP.

Am J Epidemiol. 2010 May 15;171(10):1144-52. doi: 10.1093/aje/kwq062. Epub 2010 Apr 16.

7.

Risk factors for cytomegalovirus reactivation after liver transplantation: can pre-transplant cytomegalovirus antibody titers predict outcome?

Bruminhent J, Thongprayoon C, Dierkhising RA, Kremers WK, Theel ES, Razonable RR.

Liver Transpl. 2015 Apr;21(4):539-46. doi: 10.1002/lt.24078. Epub 2015 Mar 12.

8.

High seropositivity of IgG and IgM antibodies against cytomegalovirus (CMV) among HIV-1 seropositive patients in Ilorin, Nigeria.

Fowotade A, Okonko IO, Agbede OO, Suleiman ST.

Afr Health Sci. 2015 Mar;15(1):1-9. doi: 10.4314/ahs.v15i1.1.

9.

The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study.

Haider AW, Wilson PW, Larson MG, Evans JC, Michelson EL, Wolf PA, O'Donnell CJ, Levy D.

J Am Coll Cardiol. 2002 Oct 16;40(8):1408-13.

10.

Prospective study of cytomegalovirus seropositivity and risk of mortality from diabetes.

Mendy A, Gasana J, Vieira ER, Diallo H.

Acta Diabetol. 2014 Oct;51(5):723-9. doi: 10.1007/s00592-014-0573-3. Epub 2014 Mar 16.

PMID:
24633860
11.

Seroepidemiology of Epstein-Barr virus and cytomegalovirus among Israeli male young adults.

Levine H, Balicer RD, Rozhavski V, Halperin T, Shreberk M, Davidovitch N, Huerta-Hartal M, Ankol OE.

Ann Epidemiol. 2012 Nov;22(11):783-8. doi: 10.1016/j.annepidem.2012.06.099. Epub 2012 Jul 24.

PMID:
22831994
12.

Cytomegalovirus antibody level and mortality among community-dwelling older adults with stable cardiovascular disease.

Strandberg TE, Pitkala KH, Tilvis RS.

JAMA. 2009 Jan 28;301(4):380-2. doi: 10.1001/jama.2009.4. No abstract available.

PMID:
19176439
13.

Seroprevalence of cytomegalovirus IgG antibodies among pregnant women in Japan from 2009-2014.

Shigemi D, Yamaguchi S, Otsuka T, Kamoi S, Takeshita T.

Am J Infect Control. 2015 Nov;43(11):1218-21. doi: 10.1016/j.ajic.2015.06.026. Epub 2015 Aug 12.

PMID:
26277571
14.

[Investigation of cytomegalovirus seroepidemiology in Antalya with a population-based cross-sectional study and review of related data in Turkey].

Ataman S, Colak D, Günseren F, Senol Y, Colak T, Aktekin MR, Gültekin M.

Mikrobiyol Bul. 2007 Oct;41(4):545-55. Turkish.

PMID:
18173073
15.

Invited commentary: human cytomegalovirus, inflammation, cardiovascular disease, and mortality.

Crumpacker CS.

Am J Epidemiol. 2010 Aug 15;172(4):372-4. doi: 10.1093/aje/kwq174. Epub 2010 Jul 21.

PMID:
20660119
16.

Cytomegalovirus coinfection is associated with an increased risk of severe non-AIDS-defining events in a large cohort of HIV-infected patients.

Lichtner M, Cicconi P, Vita S, Cozzi-Lepri A, Galli M, Lo Caputo S, Saracino A, De Luca A, Moioli M, Maggiolo F, Marchetti G, Vullo V, d'Arminio Monforte A; ICONA Foundation Study.

J Infect Dis. 2015 Jan 15;211(2):178-86. doi: 10.1093/infdis/jiu417. Epub 2014 Jul 31.

PMID:
25081936
17.

Cytomegalovirus seropositivity is associated with herpes zoster.

Ogunjimi B, Hens N, Pebody R, Jansens H, Seale H, Quinlivan M, Theeten H, Goossens H, Breuer J, Beutels P.

Hum Vaccin Immunother. 2015;11(6):1394-9. doi: 10.1080/21645515.2015.1037999.

18.

No relation between CMV infection and mortality in the oldest old: results from the Belfrail study.

Matheï C, Adriaensen W, Vaes B, Van Pottelbergh G, Wallemacq P, Degryse J.

Age Ageing. 2015 Jan;44(1):130-5. doi: 10.1093/ageing/afu094. Epub 2014 Jul 15.

PMID:
25026957
19.

Role of cytomegalovirus sero-status in the development of secondary cardiovascular events in patients with coronary heart disease under special consideration of diabetes.

Guech-Ongey M, Brenner H, Twardella D, Hahmann H, Rothenbacher D.

Int J Cardiol. 2006 Jul 28;111(1):98-103. Epub 2005 Oct 17.

PMID:
16229909
20.

Cytomegalovirus is associated with reduced telomerase activity in the Whitehall II cohort.

Dowd JB, Bosch JA, Steptoe A, Blackburn EH, Lin J, Rees-Clayton E, Aiello AE.

Exp Gerontol. 2013 Apr;48(4):385-90. doi: 10.1016/j.exger.2013.01.016. Epub 2013 Feb 9.

Supplemental Content

Support Center